Clinical Trials Directory

Trials / Completed

CompletedNCT00109551

Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal

Zinc Supplementation Impact on Child Mortality--Nepal

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
58,000 (planned)
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
Sex
All
Age
1 Month – 36 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether daily supplementation of young children in Nepal with either zinc, iron-folic acid, or both can reduce mortality and morbidity. Young children in Nepal have numerous nutritional deficiencies and high rates of morbidity and mortality. Zinc and/or iron supplementation may be a cost-effective method for reducing these risks.

Detailed description

Mortality rates among preschool age children in Nepal and many other developing countries remain high despite significant progress made over the past 20 years. There remain significant nutritional deficiencies in these populations, especially important are vitamin and mineral deficiencies. Comparisons: In this study, we are comparing the morbidity and mortality experience for children 1-36 months of age randomized to one of four daily supplementation regimens: placebo, zinc alone, iron-folic acid alone, zinc + iron-folic acid.

Conditions

Interventions

TypeNameDescription
DRUGzinc sulphate dietary supplement
DRUGiron sulphate-folic acid dietary supplement

Timeline

Start date
2001-10-01
Completion
2006-01-01
First posted
2005-04-29
Last updated
2013-05-01

Locations

3 sites across 2 countries: United States, Nepal

Source: ClinicalTrials.gov record NCT00109551. Inclusion in this directory is not an endorsement.